Diabetes drug linked to Post-Surgery complication? new study investigates

NCT ID NCT07127406

Ongoing Knowledge-focused Sponsor: Kocaeli City Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This observational study tracks 300 adults with diabetes who take SGLT-2 inhibitors and are recovering from surgery in the intensive care unit. Researchers want to find out how often a rare type of diabetic ketoacidosis (called euglycemic DKA) occurs after surgery. The goal is to identify risk factors and improve patient safety, but this study does not test any new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If this study succeeds, it could help doctors better understand the risk of a rare but serious complication after surgery in patients taking SGLT-2 inhibitors for diabetes.
What could go wrong: This is an observational study, not a treatment trial, so it won't test any new drug or therapy. It only looks at what happens in a specific hospital setting, so results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus diabetic ketoacidosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETIC KETOACIDOSIS POSTOPERATIVE CARE

Contacts and locations

Locations

Kocaeli City Hospital

Kocaeli, İzmit, 41060, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.